# Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years

> **NCT01832454** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Chaitanya Hospital, Pune** · enrollment: 100 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

- **OTHER:** Intra thecal inj of autologous MNC

## Key facts

- **NCT ID:** NCT01832454
- **Lead sponsor:** Chaitanya Hospital, Pune
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832454, "Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01832454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*